These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9124020)
1. Staging of cardiac rejection by simultaneous administration of 123I-antimyosin and 111In-anti MHC class II antibodies. Isobe M; Sekiguchi M Acta Cardiol; 1996; 51(6):515-20. PubMed ID: 9124020 [TBL] [Abstract][Full Text] [Related]
2. Detection of cardiac rejection in mice by radioimmune scintigraphy using 123iodine-labeled anti-ICAM-1 monoclonal antibody. Isobe M; Ohtani H; Yagita H; Okumura K; Strauss HW; Yazaki Y Acta Cardiol; 1993; 48(3):235-43. PubMed ID: 8101409 [TBL] [Abstract][Full Text] [Related]
3. Scintigraphic imaging of MHC class II antigen induction in mouse kidney allografts: a new approach to noninvasive detection of early rejection. Isobe M Transpl Int; 1993; 6(5):263-9. PubMed ID: 8216702 [TBL] [Abstract][Full Text] [Related]
4. Scintigraphic detection of early cardiac rejection by iodine 123-labeled monoclonal antibody directed against monomorphic determinant of major histocompatibility complex class II antigens. Isobe M; Southern JF; Yazaki Y Am Heart J; 1994 May; 127(5):1309-17. PubMed ID: 7513490 [TBL] [Abstract][Full Text] [Related]
5. Early detection of rejection and assessment of cyclosporine therapy by 111In antimyosin imaging in mouse heart allografts. Isobe M; Haber E; Khaw BA Circulation; 1991 Sep; 84(3):1246-55. PubMed ID: 1884451 [TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule-1 induction: a sensitive and quantitative marker for cardiac allograft rejection. Ohtani H; Strauss HW; Southern JF; Tamatani T; Miyasaka M; Sekiguchi M; Isobe M J Am Coll Cardiol; 1995 Sep; 26(3):793-9. PubMed ID: 7642875 [TBL] [Abstract][Full Text] [Related]
7. Imaging the rejecting heart. In vivo detection of major histocompatibility complex class II antigen induction. Isobe M; Narula J; Southern JF; Strauss HW; Khaw BA; Haber E Circulation; 1992 Feb; 85(2):738-46. PubMed ID: 1735166 [TBL] [Abstract][Full Text] [Related]
8. Scintigraphy and immunohistology of antimyosin-Fab during graft rejection. Breuer M; Schütz A; Engelhardt M; Hammer C; Kemkes BM Angiology; 1999 Jul; 50(7):563-71. PubMed ID: 10431996 [TBL] [Abstract][Full Text] [Related]
9. Major histocompatibility complex class II antigen expression in rejecting cardiac allografts: detection using in vivo imaging with radiolabeled monoclonal antibody. McGhie AI; Radovancevic B; Capek P; Moore WH; Kasi L; Lamki L; Clubb FJ; Frazier OH; Willerson JT Circulation; 1997 Sep; 96(5):1605-11. PubMed ID: 9315554 [TBL] [Abstract][Full Text] [Related]
10. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
11. Imaging of cardiac transplantation rejection in primates using two new antimyosin agents. Vaccarino RA; Sanchez JE; Johnson LL; Wang TS; Seldin DW; Marboe C; Egbe P; Bhatia K; Rose EA; Khaw BA J Nucl Med; 1992 Nov; 33(11):1994-9. PubMed ID: 1432161 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of biopsy classification for rejection: relation to detection of myocardial damage by monoclonal antimyosin antibody imaging. Ballester M; Bordes R; Tazelaar HD; Carrió I; Marrugat J; Narula J; Billingham ME J Am Coll Cardiol; 1998 May; 31(6):1357-61. PubMed ID: 9581733 [TBL] [Abstract][Full Text] [Related]
13. Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation. Hesse B; Mortensen SA; Folke M; Brodersen AK; Aldershvile J; Pettersson G J Heart Lung Transplant; 1995; 14(1 Pt 1):23-31. PubMed ID: 7727472 [TBL] [Abstract][Full Text] [Related]
14. Imaging of cardiac allograft rejection in dogs using indium-111 monoclonal antimyosin Fab. Addonizio LJ; Michler RE; Marboe C; Esser PE; Johnson LL; Seldin DW; Gersony WM; Alderson PO; Rose EA; Cannon PJ J Am Coll Cardiol; 1987 Mar; 9(3):555-64. PubMed ID: 3546461 [TBL] [Abstract][Full Text] [Related]
15. Effect of cyclosporine on the uptake of monoclonal antibody to cardiac myosin. Allen MD; Shoji Y; Fujimura Y; Eary JF; Reichenbach DD; Thomas R; Gordon D J Heart Lung Transplant; 1991; 10(5 Pt 1):775-81. PubMed ID: 1958686 [TBL] [Abstract][Full Text] [Related]
16. Kinetics and dynamics of acute rejection after heterotopic heart transplantation. Schüetz A; Kemkes BM; Breuer M; Brandl U; Engelhardt M; Kugler C; Manz C; Hatz R; Gokel JM; Hammer C J Heart Lung Transplant; 1992; 11(2 Pt 1):289-99; discussion 299-300. PubMed ID: 1576135 [TBL] [Abstract][Full Text] [Related]
17. Antimyosin antibodies in cardiac rejection. Schütz A; Breuer M; Kemkes BM Ann Thorac Surg; 1997 Feb; 63(2):578-81. PubMed ID: 9033354 [TBL] [Abstract][Full Text] [Related]
18. The role of indium-111 antimyosin (Fab) imaging as a noninvasive surveillance method of human heart transplant rejection. De Nardo D; Scibilia G; Macchiarelli AG; Cassisi A; Tonelli E; Papalia U; Gallo P; Antolini M; Pitucco G; Reale A J Heart Transplant; 1989; 8(5):407-12. PubMed ID: 2795283 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal Fab antimyosin in cardiac imaging. Johnson LL Clin Cardiol; 1992 Mar; 15(3):145-53. PubMed ID: 1551261 [TBL] [Abstract][Full Text] [Related]
20. Identification of cardiac rejection in heterotopic heart transplantation using 111In-antimyosin. Nishimura T; Sada M; Sasaki H; Yutani C; Hayashi M; Amemiya H; Fujita T; Akutsu T; Manabe H Eur J Nucl Med; 1987; 13(7):343-7. PubMed ID: 3322830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]